| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.045 | 0.4 |